Fortress Biotech, Inc. - COM NEW (FBIO)

CUSIP: 34960Q307

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / COM NEW
Total 13F shares
4,912,339
Share change
+94,794
Total reported value
$7,662,384
Put/Call ratio
265%
Price per share
$1.56
Number of holders
46
Value change
+$48,360
Number of buys
21
Number of sells
20

Quarterly Holders Quick Answers

What is CUSIP 34960Q307?
CUSIP 34960Q307 identifies FBIO - Fortress Biotech, Inc. - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Fortress Biotech, Inc. - COM NEW (FBIO) as of Q1 2025

As of 31 Mar 2025, Fortress Biotech, Inc. - COM NEW (FBIO) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 4,912,339 shares. The largest 10 holders included Cambridge Investment Research Advisors, Inc., VANGUARD GROUP INC, PVG ASSET MANAGEMENT CORP, Nantahala Capital Management, LLC, Kestra Advisory Services, LLC, ENVESTNET ASSET MANAGEMENT INC, GEODE CAPITAL MANAGEMENT, LLC, SHIKIAR ASSET MANAGEMENT INC, BlackRock, Inc., and HB Wealth Management, LLC. This page lists 46 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.